Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

High Grade Endometrial Carcinoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Carcinoma
Genitourinary System Carcinoma
Female Reproductive System Carcinoma
Endometrial Carcinoma
High Grade Endometrial Carcinoma

Subtype

High Grade Endometrial Carcinoma

CI-CAN-00007804Explore in graph →

18 active trials2 evidence items

NCIt: C190680

Overview
Statistics
Survival
Genomics
Variants & evidence2
Drugs1
Trials63
Research
Rankings
Sources & provenance

Data completeness3 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (no data yet)
Evidence (data present)
Therapies (no data yet)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A group of aggressive endometrial carcinomas with high-grade histological features. It includes high grade endometrial endometrioid adenocarcinoma, endometrial clear cell adenocarcinoma, endometrial serous adenocarcinoma, and endometrial undifferentiated carcinoma.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Endometrial CarcinomaSubtype

Children (4)

ncit

Endometrial Clear Cell Adenocarcinoma
Endometrial High Grade Endometrioid Adenocarcinoma
Endometrial Serous Adenocarcinoma1 sub
Endometrial Undifferentiated Carcinoma

5 descendants in total; counters on this page aggregate over all of them.

Anatomy

Anatomical sites

Genitourinary SystemC156482

Record

Identity

CancerIndex ID: CI-CAN-00007804
Entity type: Subtype
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 7
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active): 63 / 18

Publications (all / 5y)

95 / 49

Evidence items

2

Genes / variants

1 / 1

Drugs (any / approved)

1 / 0

Genomic cohorts

0

Epidemiology / survival obs.

0 / 0

Data updated 6 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (0)

Only the preferred name is recorded so far.

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

US deaths8,608countUnited States · 2024 · both sexes · all agescdc-wonderObservedrank #18 of 31 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Malignant Uterine Corpus Neoplasm (registry level) — open Malignant Uterine Corpus Neoplasm
US new cases62,434countUnited States · 2023 · both sexes · all agescdc-uscsObservedrank #9 of 32 (USA · both sexes · all ages · 2023 · top-level cancers)figures shown for Malignant Uterine Corpus Neoplasm (registry level) — open Malignant Uterine Corpus Neoplasm
US age-standardized mortality1.9per 100,000United States · 2024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderObservedrank #8 of 28 (USA · Female · all ages · 2024 · top-level cancers)figures shown for Malignant Uterine Corpus Neoplasm (registry level) — open Malignant Uterine Corpus Neoplasm
Active trials18countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #455 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials9countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #452 of 1,284 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items2countaccepted CIViC items · entity + descendantscivicComputedrank #342 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months17countPubMed records · stored query · 12-month windowpubmedComputedrank #775 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts0countopen GDC projects · entity + descendantsgdcComputednot in a current ranking snapshot

Data updated 6 hours agoSource updated unknownregistry figures: cdc-wonder · latest year available per metric · counters aggregate over descendants